Vascular endothelial and smooth muscle cells are unlikely to be major sites of latency of human cytomegalovirus in vivo
- PMID: 15483249
- DOI: 10.1099/vir.0.80285-0
Vascular endothelial and smooth muscle cells are unlikely to be major sites of latency of human cytomegalovirus in vivo
Abstract
Human cytomegalovirus (HCMV) is a frequent cause of major disease following primary infection or reactivation from latency in immunocompromised patients. It has also been suggested that there may be a link between HCMV and vascular disease. Both smooth muscle and endothelial cells are targets for primary infection with HCMV and have also been postulated as potential sites of HCMV latency. One of the most intensely studied sites of HCMV latency is the cells of the myeloid lineage; there is increasing evidence that the myeloid and endothelial lineages arise from a common precursor in the bone marrow, suggesting that endothelial cells could be another route of HCMV dissemination. However, using a highly sensitive PCR capable of detecting endogenous HCMV in myeloid cells, the HCMV genome in endothelial and smooth muscle cells isolated from the saphenous veins of seropositive patients was not detected. These data suggest that vascular endothelial and smooth muscle cells are unlikely to be important sites of HCMV latency in vivo.
Similar articles
-
iTRAQ-Based Proteomics Analysis of Human Cytomegalovirus Latency and Reactivation in T98G Cells.J Virol. 2022 Jan 26;96(2):e0147621. doi: 10.1128/JVI.01476-21. Epub 2021 Nov 3. J Virol. 2022. PMID: 34730396 Free PMC article.
-
Circulating dendritic cells isolated from healthy seropositive donors are sites of human cytomegalovirus reactivation in vivo.J Virol. 2013 Oct;87(19):10660-7. doi: 10.1128/JVI.01539-13. Epub 2013 Jul 24. J Virol. 2013. PMID: 23885077 Free PMC article.
-
Evaluation of human cytomegalovirus latency in alveolar macrophages.Am J Respir Crit Care Med. 1994 Feb;149(2 Pt 1):495-9. doi: 10.1164/ajrccm.149.2.8306052. Am J Respir Crit Care Med. 1994. PMID: 8306052
-
Aspects of human cytomegalovirus latency and reactivation.Curr Top Microbiol Immunol. 2008;325:297-313. doi: 10.1007/978-3-540-77349-8_17. Curr Top Microbiol Immunol. 2008. PMID: 18637513 Review.
-
Rethinking human cytomegalovirus latency reservoir.Ann N Y Acad Sci. 2023 Jun;1524(1):30-36. doi: 10.1111/nyas.14994. Epub 2023 Apr 7. Ann N Y Acad Sci. 2023. PMID: 37026581 Review.
Cited by
-
Innate and adaptive effector immune drivers of cytomegalovirus disease in lung transplantation: a double-edged sword.Front Transplant. 2024 Jun 10;3:1388393. doi: 10.3389/frtra.2024.1388393. eCollection 2024. Front Transplant. 2024. PMID: 38993763 Free PMC article. Review.
-
Cytomegalovirus and Cardiovascular Disease: A Hypothetical Role for Viral G-Protein-Coupled Receptors in Hypertension.Am J Hypertens. 2023 Aug 5;36(9):471-480. doi: 10.1093/ajh/hpad045. Am J Hypertens. 2023. PMID: 37148218 Free PMC article. Review.
-
Identification of viral-mediated pathogenic mechanisms in neurodegenerative diseases using network-based approaches.Brief Bioinform. 2021 Nov 5;22(6):bbab141. doi: 10.1093/bib/bbab141. Brief Bioinform. 2021. PMID: 34237135 Free PMC article.
-
HCMV Antivirals and Strategies to Target the Latent Reservoir.Viruses. 2021 May 1;13(5):817. doi: 10.3390/v13050817. Viruses. 2021. PMID: 34062863 Free PMC article. Review.
-
Where do we Stand after Decades of Studying Human Cytomegalovirus?Microorganisms. 2020 May 8;8(5):685. doi: 10.3390/microorganisms8050685. Microorganisms. 2020. PMID: 32397070 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources